Project Grant HT94252310698
Award Date
9/1/23
Completion Date
8/31/26
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
The Regents of the University of Michigan received a $312,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 2-year grant, awarded on February 1, 2024, supports research to investigate "An Unexpected Role for the Ubiquitin Proteasome System in Repeat Associated Non-AUG Translation." This basic and translational biomedical research aims to advance understanding and treatment of neurological disorders...
This $1,100,747 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, funds advanced biomedical research by the Regents of the University of Michigan to engineer antibody-drug conjugates. The goal is to coordinate the innate and adaptive immune systems for curative responses to diseases. This 3-year award, running from April 2025 to March 2028, supports cutting-edge research to transform healthcare for military service...
This Project Grant award of $546,000.00 from the Defense Health Agency supports research at the Regents of the University of Michigan to develop a novel lectin for targeting T-cell lymphomas. The award is part of the Military Medical Research and Development program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for service members and the public through innovative and impactful research. The 3-year award began on September 1, 2023 and will...
The Defense Health Agency awarded a $607,377 Project Grant to the Regents of the University of Michigan to fund a 2-year research project titled "A NEW IDEA FOR ADVANCING AXITINIB-BASED THERAPY IN RECURRENT AND METASTATIC HNSCC." This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. The University of Michigan, a leading...
This $1,206,372 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) funds research by the Regents of the University of Michigan to study the role of primary cilia alterations in the pathogenesis and treatment of systemic sclerosis. The research aims to advance understanding of this condition and explore potential new treatment approaches. The award commenced on April 15, 2025 and is scheduled for completion by April...
This $1,404,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan, Office of Research and Sponsored Projects (doing business as the University of Michigan) on September 1, 2023. The funding will support research to target the lipid kinase PIKfyve in neuroendocrine prostate cancer over a 3-year period ending on August 31, 2026. The University of Michigan is a leading U.S....
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $467,742 Project Grant to the Regents of the University of Michigan to optimize a risk stratification model for ovarian cancer. The award will support research activities from September 1, 2024 through August 31, 2026. The University of Michigan, a top public research institution, has extensive experience conducting federal research and development projects for agencies such as the...
The University of Michigan was awarded a $624,000.00 Cooperative Agreement by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. This 2-year award, effective from September 15, 2024 to September 14, 2026, will support Phase 1/2 clinical trials assessment of new kidney cancer therapeutics. Through this project, the University of Michigan will leverage its expertise in cancer research, clinical trials, and therapeutics development...
This Project Grant award of $731,980.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Regents of the University of Michigan. The award will fund a research project titled "A DATA-DRIVEN APPROACH TO INDIVIDUALIZED CONCUSSION RISK PREDICTION IN U.S. SERVICE ACADEMY CADETS AND MIDSHIPMEN" from August 1, 2024 to July 31, 2027. The project aims to develop an individualized concussion risk prediction model for...
The Department of Defense's Defense Health Agency awarded a $1,500,000 Project Grant to the Regents of the University of Michigan to develop "Regenerative Peripheral Nerve Interfaces to Enhance Function and Sensation in People with Transfemoral Amputation" over 4 years, from September 1, 2023 to August 31, 2027. This grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for Service Members...